• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新评估(99m)Tc-抑肽酶闪烁扫描术在淀粉样蛋白成像中的潜力和局限性。

Re-evaluating the potentials and limitations of (99m)Tc-aprotinin scintigraphy for amyloid imaging.

作者信息

Minamimoto Ryogo, Kubota Kazuo, Ishii Kenji, Morooka Miyako, Okasaki Momoko, Miyata Yoko, Nakajima Kazuhiko, Sato Takashi, Igari Toru, Hirai Risen, Okazaki Osamu

机构信息

Division of Nuclear Medicine, Department of Radiology, National Center for Global Health and Medicine Tokyo, Japan.

出版信息

Am J Nucl Med Mol Imaging. 2013 Apr 9;3(3):261-71. Print 2013.

PMID:23638337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3627522/
Abstract

The definitive diagnosis of amyloidosis is made histologically with Congo red stain. Noninvasive imaging techniques for amyloidosis are beneficial for early and definite diagnosis of amyloid deposition in the body. (99m)Tc-aprotinin has the benefit of detecting amyloid deposits mainly in the heart, but it can also detect a wide range of lesions in other locations. The usefulness and limitations of (99m)Tc-Aprotinin scintigraphy for amyloid imaging were re-evaluated based on results from 25 patients (15 men and 10 women; median age, 62.9 y; range, 34-83 y). In addition, other nuclear tracers for imaging amyloidosis are discussed. Of the 25 patients with suspected amyloidosis, 19 patients were proven to have amyloid deposits by histopathological diagnosis. Major (99m)Tc-aprotinin positive sites were confirmed in the myocardium, thyroid, large joints, vertebrae, colon, and lungs. If (99m)Tc-Aprotinin images showed positive findings, the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of existing amyloid deposits were 94.7, 33.3, 81.8, and 66.7%, respectively. For analysis based on biopsy region, the sensitivity, specificity, PPV, and NPV of existing amyloid deposition were 30.6, 82.6, 73.3, and 43.2%, respectively. (99m)Tc-Aprotinin has a high potential for diagnosis of amyloid deposition in body; however, due to its physiological uptake, its potential is limited for detection of amyloid deposits in the liver, kidney, and spleen.

摘要

淀粉样变性的确诊需通过刚果红染色进行组织学诊断。淀粉样变性的非侵入性成像技术有助于早期明确诊断体内的淀粉样蛋白沉积。(99m)Tc - 抑肽酶有助于检测主要在心脏的淀粉样蛋白沉积,但也能检测其他部位的多种病变。基于25例患者(15例男性和10例女性;中位年龄62.9岁;范围34 - 83岁)的结果,对(99m)Tc - 抑肽酶闪烁扫描术用于淀粉样成像的有效性和局限性进行了重新评估。此外,还讨论了用于淀粉样变性成像的其他核素示踪剂。在25例疑似淀粉样变性的患者中,19例经组织病理学诊断证实有淀粉样蛋白沉积。(99m)Tc - 抑肽酶主要在心肌、甲状腺、大关节、椎骨、结肠和肺部呈阳性。如果(99m)Tc - 抑肽酶图像显示阳性结果,现有淀粉样蛋白沉积的敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)分别为94.7%、33.3%、81.8%和66.7%。基于活检部位分析,现有淀粉样蛋白沉积的敏感性、特异性、PPV和NPV分别为30.6%、82.6%、73.3%和43.2%。(99m)Tc - 抑肽酶在诊断体内淀粉样蛋白沉积方面具有很大潜力;然而,由于其生理摄取,其在检测肝脏、肾脏和脾脏中淀粉样蛋白沉积的潜力有限。

相似文献

1
Re-evaluating the potentials and limitations of (99m)Tc-aprotinin scintigraphy for amyloid imaging.重新评估(99m)Tc-抑肽酶闪烁扫描术在淀粉样蛋白成像中的潜力和局限性。
Am J Nucl Med Mol Imaging. 2013 Apr 9;3(3):261-71. Print 2013.
2
Performance of Tc-aprotinin scintigraphy for diagnosing light chain (AL) cardiac amyloidosis confirmed by endomyocardial biopsy.经心内膜心肌活检确诊的轻链(AL)型心脏淀粉样变性患者的锝标记抑肽酶闪烁扫描术的诊断效能。
J Nucl Cardiol. 2020 Aug;27(4):1145-1153. doi: 10.1007/s12350-019-01868-9. Epub 2019 Oct 7.
3
99mTc-aprotinin scintigraphy in amyloidosis.99m锝-抑肽酶闪烁扫描术在淀粉样变性中的应用
J Nucl Med. 2003 Feb;44(2):177-83.
4
Significance of C-PIB PET/CT in cardiac amyloidosis compared with Tc-aprotinin scintigraphy: A pilot study.C-PIB PET/CT 与 Tc-aprotinin 闪烁显像在心脏淀粉样变性诊断中的对比:一项初步研究。
J Nucl Cardiol. 2020 Feb;27(1):202-209. doi: 10.1007/s12350-018-1260-5. Epub 2018 Mar 27.
5
Lung amyloid nodule detected by 99mTc-aprotinin scintigraphy.99mTc-抑肽酶闪烁扫描检测到肺淀粉样结节。
Ann Nucl Med. 2012 Jul;26(6):522-6. doi: 10.1007/s12149-012-0606-3. Epub 2012 May 19.
6
Preliminary experience of 99mTc-Aprotinin scintigraphy in amyloidosis.99mTc-抑肽酶闪烁扫描术在淀粉样变性中的初步经验。
Eur J Haematol. 2007 Dec;79(6):494-500. doi: 10.1111/j.1600-0609.2007.00963.x. Epub 2007 Nov 5.
7
[Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis].[99m锝焦磷酸盐(Tc-99m PYP)心肌闪烁显像对2例家族性淀粉样多神经病和1例继发性淀粉样变性心脏受累的无创诊断]
Kaku Igaku. 1989 Dec;26(12):1537-43.
8
Imaging of cardiac amyloidosis by (99m)Tc-PYP scintigraphy.用(99m)锝-焦磷酸显像对心脏淀粉样变性进行成像。
Hell J Nucl Med. 2015 Sep-Dec;18 Suppl 1:42-50.
9
Diagnostic value of Tc-ethambutol scintigraphy in tuberculosis: compared to microbiological and histopathological tests.锝-乙胺丁醇闪烁扫描术在结核病中的诊断价值:与微生物学和组织病理学检查的比较
Ann Nucl Med. 2018 Jan;32(1):60-68. doi: 10.1007/s12149-017-1220-1. Epub 2017 Dec 5.
10
Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.3,3-二膦酰基-1,2-丙二酸闪烁扫描术在系统性淀粉样变性中的应用及局限性
Eur Heart J Cardiovasc Imaging. 2014 Nov;15(11):1289-98. doi: 10.1093/ehjci/jeu107. Epub 2014 Jun 16.

引用本文的文献

1
A Narrative Review of Tc-Aprotinin in the Diagnosis of Cardiac Amyloidosis and a New Life for an Unfairly Abandoned Drug.关于抑肽酶锝在心脏淀粉样变性诊断中的叙述性综述以及一种被不公平弃用药物的新用途
Biomedicines. 2022 Jun 10;10(6):1377. doi: 10.3390/biomedicines10061377.
2
Multimodality Imaging in the Evaluation and Management of Cardiac Amyloidosis.心脏淀粉样变评估与管理中的多模态成像
Semin Nucl Med. 2020 Jul;50(4):295-310. doi: 10.1053/j.semnuclmed.2020.01.001. Epub 2020 Feb 9.
3
Molecular Imaging of Cardiac Amyloidosis.心肌淀粉样变的分子影像学
J Nucl Med. 2020 Jul;61(7):965-970. doi: 10.2967/jnumed.120.245381. Epub 2020 Jun 1.
4
Performance of Tc-aprotinin scintigraphy for diagnosing light chain (AL) cardiac amyloidosis confirmed by endomyocardial biopsy.经心内膜心肌活检确诊的轻链(AL)型心脏淀粉样变性患者的锝标记抑肽酶闪烁扫描术的诊断效能。
J Nucl Cardiol. 2020 Aug;27(4):1145-1153. doi: 10.1007/s12350-019-01868-9. Epub 2019 Oct 7.
5
Bifunctional amyloid-reactive peptide promotes binding of antibody 11-1F4 to diverse amyloid types and enhances therapeutic efficacy.双功能淀粉样蛋白反应肽促进抗体 11-1F4 与多种淀粉样蛋白类型结合,并增强治疗效果。
Proc Natl Acad Sci U S A. 2018 Nov 13;115(46):E10839-E10848. doi: 10.1073/pnas.1805515115. Epub 2018 Oct 30.
6
Significance of C-PIB PET/CT in cardiac amyloidosis compared with Tc-aprotinin scintigraphy: A pilot study.C-PIB PET/CT 与 Tc-aprotinin 闪烁显像在心脏淀粉样变性诊断中的对比:一项初步研究。
J Nucl Cardiol. 2020 Feb;27(1):202-209. doi: 10.1007/s12350-018-1260-5. Epub 2018 Mar 27.
7
Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.用于心脏淀粉样变性的靶向核成像探针
Curr Cardiol Rep. 2017 Jul;19(7):59. doi: 10.1007/s11886-017-0868-4.
8
(99m)Tc-aprotinin - optimisation and validation of radiolabelling kits for routine preparation for diagnostic imaging of amyloidosis.(99m)Tc-抑肽酶——用于淀粉样变性病诊断成像常规制备的放射性标记试剂盒的优化与验证
J Labelled Comp Radiopharm. 2016 Apr;59(4):171-4. doi: 10.1002/jlcr.3381. Epub 2016 Feb 28.

本文引用的文献

1
A novel method for quantifying peripheral tissue amyloid load by using the radiolabeled amyloidophilic peptide, p5.一种通过放射性标记淀粉样蛋白亲和肽 p5 定量外周组织淀粉样蛋白负荷的新方法。
Amyloid. 2013 Mar;20(1):21-6. doi: 10.3109/13506129.2012.757216. Epub 2013 Jan 17.
2
In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET.利用 11C-PIB 和 PET 进行体内可视化心脏中的淀粉样沉积物。
J Nucl Med. 2013 Feb;54(2):213-20. doi: 10.2967/jnumed.111.102053. Epub 2012 Dec 13.
3
Amyloid imaging mismatch.淀粉样蛋白成像不匹配。
Clin Nucl Med. 2012 Aug;37(8):807-9. doi: 10.1097/RLU.0b013e318251e1d3.
4
Lung amyloid nodule detected by 99mTc-aprotinin scintigraphy.99mTc-抑肽酶闪烁扫描检测到肺淀粉样结节。
Ann Nucl Med. 2012 Jul;26(6):522-6. doi: 10.1007/s12149-012-0606-3. Epub 2012 May 19.
5
Molecular imaging of amyloidosis: will the heart be the next target after the brain?淀粉样变性的分子影像学:继大脑之后,心脏会成为下一个目标吗?
Curr Cardiol Rep. 2012 Apr;14(2):226-33. doi: 10.1007/s11886-011-0239-5.
6
18F-FDG PET/CT in primary AL hepatic amyloidosis associated with multiple myeloma.18F-FDG PET/CT 在原发性 AL 肝淀粉样变性伴多发性骨髓瘤中的应用。
Korean J Radiol. 2011 Sep-Oct;12(5):634-7. doi: 10.3348/kjr.2011.12.5.634. Epub 2011 Aug 24.
7
Tracheobronchial FDG uptake in primary amyloidosis detected by PET/CT.PET/CT 检测原发性淀粉样变性的气管支气管 FDG 摄取。
Clin Nucl Med. 2011 Aug;36(8):723-4. doi: 10.1097/RLU.0b013e318219b16e.
8
Visualization of amyloid arthropathy in light-chain systemic amyloidosis on F-18 FDG PET/CT scan.F-18 FDG PET/CT 扫描中轻链系统性淀粉样变的淀粉样关节病的可视化。
Clin Nucl Med. 2011 Jan;36(1):52-3. doi: 10.1097/RLU.0b013e3181feefd4.
9
Radioimmunodetection of amyloid deposits in patients with AL amyloidosis.放射性免疫检测 AL 淀粉样变性患者的淀粉样沉积物。
Blood. 2010 Sep 30;116(13):2241-4. doi: 10.1182/blood-2010-03-273797. Epub 2010 Jun 3.
10
Nuclear imaging in cardiac amyloidosis.心脏淀粉样变的核成像
Eur J Nucl Med Mol Imaging. 2009 Apr;36(4):702-14. doi: 10.1007/s00259-008-1037-1. Epub 2009 Jan 21.